EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CD43: recent advances and emerging functions

Mariana Diupotex, Veronica Rojo-Leon, Luis Eduardo Chipres-Naranjo, Estefanía Alemán-Navarro, Emiliano Rubio-Blancas, Alejandra Carrillo-Carlos, Gabriel Ramírez-Vilchis, Jazmin López-Acosta iD, José Luis Maravillas-Montero, Yvonne Rosenstein iD

Journal of Leukocyte Biology · 03.07.2026 · 118 (7)

DOI: 10.1093/jleuko/qiag084 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 27.06.2026. Verfasst von Mariana Diupotex und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Av. Universidad 2001, Chamilpa…. Hauptthemen laut MEDLINE: Leukosialin. Die Arbeit nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Dirección General de Personal Académico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Originally characterized for its roles in T-cell activation and adhesion, CD43 is a prominent mucin-like sialoglycoprotein expressed on hematopoietic cells. CD43 is broadly expressed across leukocyte populations, with its levels, molecular configuration, and ligand interactions varying by cell type, activation state, and differentiation. Growing evidence indicates that CD43 functions as a context-dependent regulator, integrating microenvironmental cues and dynamic glycosylation states with the biophysical organization of the cell surface and intracellular signaling. CD43 simultaneously participates in immune activation, regulation, and dysfunction, depending on the cellular and environmental context. CD43 is associated with distinct, sometimes contrasting, functional outcomes across diverse physiological and pathological settings. For instance, it has been linked to altered leukocyte trafficking and activation, while in infectious diseases, it influences host–pathogen interactions and the balance between protective immunity and immunopathology. Furthermore, in cancer, changes in CD43 signaling, glycosylation, and ligand engagement modulate immune recognition, effector responses, and inflammatory processes, contributing to immune evasion. Here, we review current knowledge on the regulation of CD43 expression, its structural organization, and ligand interactions. We discuss the potential role of CD43 across different disease settings, proposing it as a dynamic, adaptable regulator of immune responses and a potential therapeutic target in immune-mediated diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukosialinHumansAnimalsSignal TransductionNeoplasms

Stichwörter der Autor:innen

CD43cancer immunologyhost–pathogen interactionsimmune regulationleukocyte function

Substanzen

Leukosialin

Autor:innen und Institutionen

  • Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Av. Universidad 2001, Chamilpa, 62210 Cuernavaca, Morelos, México.
  • Secretaría de Ciencia, Humanidades, Tecnología e Inovación, Av. Insurgentes Sur 1582, Crédito Constructor, Benito Juárez, 03940 Ciudad de México, México.
  • Posgrado en Ciencias Bioquímicas, Universidad Nacional Autónoma de México, Unidad de Posgrado, Ciudad Universitaria, Coyoacán, 04510 Ciudad de México, México.
  • Licenciatura en Ciencias, Instituto de Investigaciones en Ciencias Básicas y Aplicadas, Universidad Autónoma del Estado de Morelos, Av. Universidad 1001, Chamilpa, 62210 Cuernavaca, Morelos, México.
  • Licenciatura en Ciencias Genómicas, Universidad Nacional Autónoma de México, Av. Universidad s/n, Chamilpa, 62210 Cuernavaca, Morelos, México.
  • Licenciatura en Ciencias Biomédicas, Universidad Autónoma de Occidente, Unidad Regional Los Mochis, Blvd. Macario Gaxiola y Carretera Internacional, 81223 Los Mochis, Sinaloa, México.

ORCID-Profile: Jazmin López-Acosta, Yvonne Rosenstein

Förderung

  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación
  • Dirección General de Personal Académico

Zitieren

APA

Diupotex, M., Rojo-Leon, V., Chipres-Naranjo, L. E., Alemán-Navarro, E., Rubio-Blancas, E., Carrillo-Carlos, A., Ramírez-Vilchis, G., López-Acosta, J., Maravillas-Montero, J. L., & Rosenstein, Y. (2026). CD43: recent advances and emerging functions. Journal of Leukocyte Biology, 118(7). https://doi.org/10.1093/jleuko/qiag084

Vancouver

Diupotex M, Rojo-Leon V, Chipres-Naranjo LE, Alemán-Navarro E, Rubio-Blancas E, Carrillo-Carlos A, et al. CD43: recent advances and emerging functions. Journal of Leukocyte Biology. 2026;118(7). doi:10.1093/jleuko/qiag084

BibTeX
@article{Diupotex2026,
  author = {Diupotex, Mariana and Rojo-Leon, Veronica and Chipres-Naranjo, Luis Eduardo and Alemán-Navarro, Estefanía and Rubio-Blancas, Emiliano and Carrillo-Carlos, Alejandra and Ramírez-Vilchis, Gabriel and López-Acosta, Jazmin and Maravillas-Montero, José Luis and Rosenstein, Yvonne},
  title = {CD43: recent advances and emerging functions},
  journal = {Journal of Leukocyte Biology},
  year = {2026},
  volume = {118},
  number = {7},
  doi = {10.1093/jleuko/qiag084}
}
Kostenlos starten →